JP2017533203A - 半合成法 - Google Patents
半合成法 Download PDFInfo
- Publication number
- JP2017533203A JP2017533203A JP2017521573A JP2017521573A JP2017533203A JP 2017533203 A JP2017533203 A JP 2017533203A JP 2017521573 A JP2017521573 A JP 2017521573A JP 2017521573 A JP2017521573 A JP 2017521573A JP 2017533203 A JP2017533203 A JP 2017533203A
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- group
- hydrogen
- alkoxy
- alkylene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 0 CN(C)[C@@](C(CC(Cc(c(*)cc(*)c1O)c1C1=O)C1=C1O)[C@]11O)C(O)=C(C(N)=O)C1=O Chemical compound CN(C)[C@@](C(CC(Cc(c(*)cc(*)c1O)c1C1=O)C1=C1O)[C@]11O)C(O)=C(C(N)=O)C1=O 0.000 description 3
- RDRDQBHUDBIVHT-YCTKZLFKSA-N CN(C)[C@@H](C1CC2Cc(cc3)c4c(O)c3N)C(O)=C(C(N)=O)C3=[O][C@]13C(O)=C2C4=O Chemical compound CN(C)[C@@H](C1CC2Cc(cc3)c4c(O)c3N)C(O)=C(C(N)=O)C3=[O][C@]13C(O)=C2C4=O RDRDQBHUDBIVHT-YCTKZLFKSA-N 0.000 description 2
- JTYKBLZOTIKGLU-OJBBSUIXSA-N CN(C)[C@@H](C(CC(Cc(c(C1=O)c(c([N+]([O-])=O)c2)O)c2F)C1=C1O)[C@]11O)C(O)=C(C(N)=O)C1=N Chemical compound CN(C)[C@@H](C(CC(Cc(c(C1=O)c(c([N+]([O-])=O)c2)O)c2F)C1=C1O)[C@]11O)C(O)=C(C(N)=O)C1=N JTYKBLZOTIKGLU-OJBBSUIXSA-N 0.000 description 1
- ABOKOYYYGCIPIK-KWLNVPAYSA-N CN(C)[C@@H](C(CC(Cc(c(C1=O)c2O)ccc2N)C1=C1O)[C@]11O)C(O)=C(C(N)=O)C1=N Chemical compound CN(C)[C@@H](C(CC(Cc(c(C1=O)c2O)ccc2N)C1=C1O)[C@]11O)C(O)=C(C(N)=O)C1=N ABOKOYYYGCIPIK-KWLNVPAYSA-N 0.000 description 1
- HLFSMUUOKPBTSM-UDHQDRSKSA-N CN(C)[C@@H](C(CC(Cc(c(F)cc(NC(CN1CCCC1)=O)c1O)c1C1=O)C1=C1O)[C@]11O)C(O)=C(C(N)=O)C1=O Chemical compound CN(C)[C@@H](C(CC(Cc(c(F)cc(NC(CN1CCCC1)=O)c1O)c1C1=O)C1=C1O)[C@]11O)C(O)=C(C(N)=O)C1=O HLFSMUUOKPBTSM-UDHQDRSKSA-N 0.000 description 1
- ZKTYHFZIDPAQIY-IWPHMJMQSA-N CN(C)[C@@H](C1CC2Cc(c3c(c(N)c4)O)c4F)C(O)=C(C(N)=O)C4=[O][C@]14C(O)=C2C3=O Chemical compound CN(C)[C@@H](C1CC2Cc(c3c(c(N)c4)O)c4F)C(O)=C(C(N)=O)C4=[O][C@]14C(O)=C2C3=O ZKTYHFZIDPAQIY-IWPHMJMQSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/15—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/24—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton
- C07C237/26—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton of a ring being part of a condensed ring system formed by at least four rings, e.g. tetracycline
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C245/00—Compounds containing chains of at least two nitrogen atoms with at least one nitrogen-to-nitrogen multiple bond
- C07C245/20—Diazonium compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/06—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with radicals, containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/02—Ortho- or ortho- and peri-condensed systems
- C07C2603/40—Ortho- or ortho- and peri-condensed systems containing four condensed rings
- C07C2603/42—Ortho- or ortho- and peri-condensed systems containing four condensed rings containing only six-membered rings
- C07C2603/44—Naphthacenes; Hydrogenated naphthacenes
- C07C2603/46—1,4,4a,5,5a,6,11,12a- Octahydronaphthacenes, e.g. tetracyclines
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462067697P | 2014-10-23 | 2014-10-23 | |
| US62/067,697 | 2014-10-23 | ||
| PCT/US2015/057167 WO2016065290A1 (en) | 2014-10-23 | 2015-10-23 | Semi-synthesis procedures |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2017533203A true JP2017533203A (ja) | 2017-11-09 |
| JP2017533203A5 JP2017533203A5 (cg-RX-API-DMAC7.html) | 2018-11-29 |
Family
ID=54478255
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017521573A Pending JP2017533203A (ja) | 2014-10-23 | 2015-10-23 | 半合成法 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US10087157B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3209642A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2017533203A (cg-RX-API-DMAC7.html) |
| CN (1) | CN107108472B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2015335661A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2964957A1 (cg-RX-API-DMAC7.html) |
| EA (1) | EA201790897A1 (cg-RX-API-DMAC7.html) |
| MA (1) | MA40836A (cg-RX-API-DMAC7.html) |
| MX (1) | MX369167B (cg-RX-API-DMAC7.html) |
| WO (1) | WO2016065290A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2890673T3 (en) | 2012-08-31 | 2019-03-18 | Tetraphase Pharmaceuticals Inc | tetracycline |
| MA40836A (fr) | 2014-10-23 | 2017-08-29 | Tetraphase Pharmaceuticals Inc | Procédures de semi-synthèse |
| WO2017097891A1 (en) | 2015-12-10 | 2017-06-15 | Sandoz Ag | Crystalline eravacycline |
| CN107759503A (zh) * | 2016-08-16 | 2018-03-06 | 四川科伦博泰生物医药股份有限公司 | 一种四环素衍生物及其用途 |
| DK3529236T3 (da) * | 2016-10-19 | 2024-05-13 | Tetraphase Pharmaceuticals Inc | Krystalformer af eravacyclin |
| CN111362829B (zh) * | 2018-12-26 | 2021-11-30 | 浙江昌海制药有限公司 | 一种米诺环素二对氯苯磺酸盐晶型及其制备方法和应用 |
| CN109734668B (zh) * | 2019-03-08 | 2020-06-23 | 杭州华樾新材料有限公司 | 四氟硼酸盐离子液体的合成方法 |
| CN110156624B (zh) * | 2019-05-29 | 2022-03-08 | 河北冀衡药业股份有限公司 | 一种米诺环素及其衍生物的合成方法 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2011530534A (ja) * | 2008-08-08 | 2011-12-22 | テトラフェース ファーマシューティカルズ，インコーポレイテッド | Ｃ７−フルオロ置換テトラサイクリン化合物 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB935384A (en) * | 1959-03-30 | 1963-08-28 | Pfizer & Co C | Tetracycline derivatives and preparation thereof |
| US3239499A (en) * | 1961-05-19 | 1966-03-08 | Pfizer & Co C | Tetracycline derivative |
| CN1961885A (zh) * | 2001-10-05 | 2007-05-16 | 泰特拉吉尼克斯医药公司 | 四环素衍生物在制药中的应用 |
| US9073829B2 (en) | 2009-04-30 | 2015-07-07 | President And Fellows Of Harvard College | Synthesis of tetracyclines and intermediates thereto |
| WO2011025982A2 (en) * | 2009-08-28 | 2011-03-03 | Tetraphase Pharmaceuticals, Inc. | Tetracycline compounds |
| DK2552890T3 (en) * | 2010-03-31 | 2017-04-03 | Tetraphase Pharmaceuticals Inc | POLYCYCLIC TETRACYCLINE COMPOUNDS |
| WO2012047907A1 (en) * | 2010-10-04 | 2012-04-12 | President And Fellows Of Harvard College | Synthesis of c5-substituted tetracyclines, uses thereof, and intermediates thereto |
| MA40836A (fr) | 2014-10-23 | 2017-08-29 | Tetraphase Pharmaceuticals Inc | Procédures de semi-synthèse |
-
2015
- 2015-10-22 MA MA040836A patent/MA40836A/fr unknown
- 2015-10-23 EA EA201790897A patent/EA201790897A1/ru unknown
- 2015-10-23 MX MX2017005223A patent/MX369167B/es active IP Right Grant
- 2015-10-23 CA CA2964957A patent/CA2964957A1/en not_active Abandoned
- 2015-10-23 JP JP2017521573A patent/JP2017533203A/ja active Pending
- 2015-10-23 WO PCT/US2015/057167 patent/WO2016065290A1/en not_active Ceased
- 2015-10-23 US US15/521,162 patent/US10087157B2/en not_active Expired - Fee Related
- 2015-10-23 CN CN201580070869.6A patent/CN107108472B/zh not_active Expired - Fee Related
- 2015-10-23 EP EP15791440.9A patent/EP3209642A1/en not_active Withdrawn
- 2015-10-23 AU AU2015335661A patent/AU2015335661A1/en not_active Abandoned
-
2018
- 2018-08-09 US US16/059,857 patent/US10618879B2/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2011530534A (ja) * | 2008-08-08 | 2011-12-22 | テトラフェース ファーマシューティカルズ，インコーポレイテッド | Ｃ７−フルオロ置換テトラサイクリン化合物 |
Non-Patent Citations (3)
| Title |
|---|
| HLAVKA, JOSEPH J.; KRAZINSKI, H.; BOOTHE, J. H.: "6-Deoxytetracyclines. IV. Photochemical displacement of a diazonium group", JOURNAL OF ORGANIC CHEMISTRY, vol. 27, JPN6019029821, 1962, pages 3674 - 5, ISSN: 0004240910 * |
| JORGE HEREDIA-MOYA, KENNETH L. KIRK: "Photochemical Schiemann Reaction in Ionic Liquids", JOURNAL OF FLUORINE CHEMISTRY, vol. 128（6）, JPN6019029826, 2007, pages 674 - 678, ISSN: 0004240912 * |
| TAKERU FURUYA, JOHANNES E. M. N. KLEIN, TOBIAS RITTER: "Carbon-Fluorine Bond Formation for the Synthesis of Aryl Fluorides", SYNTHESIS, vol. 11, JPN6019029823, 2010, pages 1804 - 1821, ISSN: 0004240911 * |
Also Published As
| Publication number | Publication date |
|---|---|
| US20190210988A1 (en) | 2019-07-11 |
| WO2016065290A1 (en) | 2016-04-28 |
| CN107108472B (zh) | 2020-03-13 |
| CA2964957A1 (en) | 2016-04-28 |
| US20170334872A1 (en) | 2017-11-23 |
| AU2015335661A1 (en) | 2017-05-04 |
| EP3209642A1 (en) | 2017-08-30 |
| CN107108472A (zh) | 2017-08-29 |
| MA40836A (fr) | 2017-08-29 |
| MX369167B (es) | 2019-10-30 |
| MX2017005223A (es) | 2017-06-21 |
| US10618879B2 (en) | 2020-04-14 |
| US10087157B2 (en) | 2018-10-02 |
| EA201790897A1 (ru) | 2017-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017533203A (ja) | 半合成法 | |
| JP6985367B2 (ja) | 新規化合物および方法 | |
| WO2010073719A1 (ja) | Ｅｇ５阻害剤 | |
| JPWO2016035847A1 (ja) | セファロスポリン誘導体の中間体およびその製造方法 | |
| CN106536479B (zh) | 用于制备β-氨基砜化合物的方法 | |
| JP2024028860A (ja) | 細胞傷害性ベンゾジアゼピン誘導体の調製方法 | |
| JP2017141215A (ja) | 新規オキソカーボン系化合物 | |
| CN108409746A (zh) | 一种含吡咯或吲哚并氮杂环烷结构的手性氧代螺环吲哚类化合物及其消旋体和制备方法 | |
| SU521837A3 (ru) | Способ получени производных бензиламина или их солей | |
| KR20240125005A (ko) | (r)-1-(1-아크릴로일피페리딘-3-일)-4-아미노-3-(4-페녹시페닐)-1h-이미다조[4,5-c]피리딘-2(3h)-온의결정질 형태 및 이의 염 | |
| ES2892161T3 (es) | Preparación de derivados de ácido 2-([1,2,3]triazol-2-il)-benzoico | |
| BG108090A (bg) | Метод за получаване на мезилатни пиперазинови производни | |
| ES2977277T3 (es) | Procesos para preparar (3R,4R)-1-bencil-n,4-dimetilpiperidin-3-amina o una de sus sales y procesos para preparar tofacitinib mediante el uso de la misma | |
| TW201831441A (zh) | 一鍋法製備有機碘化化合物之方法 | |
| JPWO2008032764A1 (ja) | 縮環複素環誘導体 | |
| JP6226363B2 (ja) | ビス−ボロンジピロメテン系色素 | |
| BR112019009793A2 (pt) | 4-((6-(2-(2,4-difluorofenil)-1,1-difluoro-2-hidróxi-3-(5-mercapto-1h-1,2,4-triazol-1-il)propil)piridin-3-il)óxi)benzonitrila e processos de preparação | |
| EP4424686A1 (en) | Complexes and ligands | |
| JP2015513562A (ja) | ヒドラジン誘導体と二酸化炭素の反応生成物 | |
| JPWO2009099169A1 (ja) | ケージド化合物 | |
| JP4903956B2 (ja) | ７−オキサビシクロ［２．２．１］ヘプト−５−エン−２−カルボン酸誘導体の製造方法 | |
| WO2002022619A1 (en) | Process for preparation of 7-oxabicyclo[2.2.1]hept-5-ene-2-carboxylic acid derivatives | |
| ES2283781T3 (es) | Procedimiento para producir un compuesto de 1,2,3-triazol. | |
| CN111410650B (zh) | 制备磺胺类药物的方法 | |
| JPH02178260A (ja) | ヒドロキシルアミン誘導体 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20181017 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20181017 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20190627 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20190801 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20191011 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20200325 |